Correlation Between Alto Neuroscience, and Citius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Citius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Citius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Citius Pharmaceuticals, you can compare the effects of market volatilities on Alto Neuroscience, and Citius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Citius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Citius Pharmaceuticals.
Diversification Opportunities for Alto Neuroscience, and Citius Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alto and Citius is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Citius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Pharmaceuticals and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Citius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Pharmaceuticals has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Citius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Citius Pharmaceuticals
Given the investment horizon of 90 days Alto Neuroscience, is expected to generate 1.16 times more return on investment than Citius Pharmaceuticals. However, Alto Neuroscience, is 1.16 times more volatile than Citius Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Citius Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 1,320 in Alto Neuroscience, on September 2, 2024 and sell it today you would lose (879.00) from holding Alto Neuroscience, or give up 66.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alto Neuroscience, vs. Citius Pharmaceuticals
Performance |
| Timeline |
| Alto Neuroscience, |
| Citius Pharmaceuticals |
Alto Neuroscience, and Citius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and Citius Pharmaceuticals
The main advantage of trading using opposite Alto Neuroscience, and Citius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Citius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Pharmaceuticals will offset losses from the drop in Citius Pharmaceuticals' long position.| Alto Neuroscience, vs. Crinetics Pharmaceuticals | Alto Neuroscience, vs. Enanta Pharmaceuticals | Alto Neuroscience, vs. Amicus Therapeutics | Alto Neuroscience, vs. Connect Biopharma Holdings |
| Citius Pharmaceuticals vs. X4 Pharmaceuticals | Citius Pharmaceuticals vs. Hookipa Pharma | Citius Pharmaceuticals vs. Mereo BioPharma Group | Citius Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |